Analysis of forecasted female mortality from pancreas malignant neoplasms in 2024 reveals Japan as consistently having the highest mortality rate, signaling an urgent need for public health interventions. Germany, Brazil, and the United Kingdom also report substantial mortality figures. Countries like Luxembourg and Iceland show remarkably low mortality rates. The most notable year-on-year increases are forecasted for South Korea and Peru, while Japan has a relatively modest growth. Over the last five years, Peru and Iceland experienced the most considerable average annual growth, signaling potential emerging health challenges.
Future trends to watch include innovations in cancer treatment and their effects on mortality rates. Additionally, demographic shifts and healthcare delivery improvements could influence these patterns, especially in rapidly developing countries. Monitoring these trends will be crucial for targeted interventions and resource allocation to manage and potentially reduce the burden of pancreatic cancer globally.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 20,530 | 2023 | +2.88% | +3.3% | View data |
| 2 | 2 Germany | 10,070 | 2023 | +1.63% | +1.96% | View data |
| 3 | 3 Brazil | 6,840 | 2023 | +3.79% | +4.08% | View data |
| 4 | 4 United Kingdom | 5,100 | 2023 | +1.57% | +2.01% | View data |
| 5 | 5 Spain | 3,920 | 2023 | +2.48% | +3.04% | View data |
| 6 | 6 South Korea | 3,630 | 2023 | +4.07% | +4.99% | View data |
| 7 | 7 Mexico | 2,760 | 2023 | +3.22% | +3.39% | View data |
| 8 | 8 Poland | 2,680 | 2023 | +1.1% | +1.17% | View data |
| 9 | 9 Canada | 2,660 | 2023 | +1.45% | +1.5% | View data |
| 10 | 10 Argentina | 2,410 | 2023 | +1.34% | +1.3% | View data |
